Martina Lušková
Embedded Files
About
About
I am a researcher and PhD student at the Insitute of Economic Studies, Charles University in Prague.
I am a teaching assistant in the Advanced Econometrics and Econometrics I courses at the Insitute of Economic Studies, Charles University in Prague.
Field of interest: Health Economics, Meta-analysis
Awards: Honorable Mention by the President of the Czech Economic Society (Young Economist Award) 2023
Current research
Current research
The Effect of Face Masks on Covid Transmission: A Meta-Analysis
Martina Lušková
Abstract:
The effect of face masks on Covid-19 transmission is crucial for the health of populations. The effectiveness of face masks in reducing the transmission of Covid-19 varies across primary evidence. To perform a quantitative meta-analysis, we collected 258 estimates from 44 primary studies together with more than 30 variables reflecting the differences among these studies. We examine publication bias by implementing various statistical tests, revealing mild evidence for the phenomenon. After controlling for publication bias, wearing a face mask is associated with a reduced risk of Covid-19 infection by 18.7% to 44%. Our contribution to other meta-analyses on this topic involves the use of Bayesian and Frequentist model averaging to identify the drivers behind the heterogeneity of the estimates. The results indicate that temperature, geographical latitude, and panel data structure increase the risk of transmission associated with mask-wearing. Furthermore, a positive effect is identified for the healthcare setup. In contrast, wearing masks during aerosol-generating procedures decreases the risk of transmission. After controlling for the heterogeneity of primary studies, the implied estimate suggests that masks reduce the risk of Covid-19 infection by 12.9% to 15.7%.
PDF is available here
Data and code are available here
Cost-Effectiveness of Women’s Vaccination Against HPV: Results for the Czech Republic
Martina Lušková & Kseniya Bortnikova
Abstract:
This paper evaluates the cost-effectiveness of vaccinating women against human papillomaviruses (HPV) in the Czech Republic, where HPV is the main cause of most cervical carcinomas. It examines the cost-effectiveness of the current reimbursement policy for HPV vaccination compared to the suggested change. Using a homogeneous multistate Markov model, we approximate transitions among states that represent the progression stages of cervical carcinoma, utilizing healthcare reimbursement data from public health insurance. The analysis reveals that increasing immunization coverage from 65.8% to 80% is cost-effective, given the threshold of 1.2 million CZK per quality-adjusted life year. Similarly, expanding the eligible age for vaccination reimbursement from 13 to include ages 13 through 15 years, while also increasing coverage, results in comparable cost-effectiveness. Despite certain limitations, our findings suggest that enhancing the immunization coverage of HPV vaccination for women is economically justified. Consequently, we advocate for the implementation of the proposed policy modifications.
PDF is available here
Contact
Contact
Page updated
Google Sites
Report abuse